DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20203956

Frequently used laboratory pathogenic bacteria and their effect on human health

Priyanka Basera, Meeta Lavania, Banwari Lal

Abstract


Interactions between micro-organisms with humans are diverse in nature; it can be beneficial or detrimental. According to WHO, 2004 rate of infectious diseases were found to be increases widely and account for 10 million deaths every year. Microorganism consider as a pathogen, when it is capable of causing diseases to human. Which further includes; the invasion in host cells and tissues, adherence to cells, persistence, release of toxic substance, and evade the host's immune system. Ability of pathogen for causing disease is termed as pathogenicity. The pathogenesis of bacterial infection comprises of initiation of the infectious process by multiplying their number in host body which further lead to the development of signs and symptoms of disease.Infectious disease usually due to the detrimental interactions, and is specific to host and pathogen.


Keywords


Pathogenic species, Microbial laboratory, Opportunistic infection, Human health

Full Text:

PDF

References


World Health Organization. World Health Report 2004 (Geneva, World Health Organization, 2004).

Peterson JW. Medical Microbiology (4thedition). Galveston (TX): University of Texas Medical Branch at Galveston; 1996.

Baarlen PV, Belkum AV, Summerbell RC, Crous PW, Thomma BPHJ. Molecular mechanisms of pathogenicity: how do pathogenic microorganisms develop cross-kingdom host jumps. FEMS Microbiol Rev. 2007;31:239-77.

Abatenh E, Gizaw B, Tsegaye Z. Contamination in a Microbiological Laboratory. Int J Res Stud Biosci. 2018;6:7-13.

Pati P. Review on Common Microbiological Contamination Found in Hospital Air. J Micro boil Pathol. 2018;2:1.

Singh K. Laboratory-Acquired Infections. Clin Infectious Diseases. 2009;49:142-7.

Ulrich N, Nagler K, Laue M, Cockell CS, Setlow P, Moeller R. Experimental studies addressing the longevity of Bacillus subtilis spores - The first data from a 500 years experiment. PLoS ONE. 2018;13(12):e0208425.

Schoni JL, Wong ACL. Bacillus cereus Food Poisoning and Its Toxins. J Food Protection. 2005;68:636-48.

Lakha SS, Velarde CGL, Chen S, Lee S, Shannon K, Fabri M, et al. A Study to Assess the Numbers and Prevalence of Bacillus cereus and Its Toxins in Pasteurized Fluid Milk. J Food Protection. 2017;80(7):1085-9.

Bottone EJ. Bacillus cereus, a Volatile Human Pathogen. Clin Microbiology Reviews. 2010;23:382-98.

Glasset B, Herbin S, Granier SA, Cavalie L, Lafeuille E, Guerin C, et al. Bacillus cereus, a serious cause of nosocomial infections: Epidemiologic and genetic survey. PLoS ONE. 2018;13(5):e0194346.

Jeon YL, Yang JJ, Kim MJ, Lim G, Cho SY, Park TS, et al. Combined Bacillus licheniformis and Bacillus subtilis infection in a patient with oesophageal perforation. J Med Microbiology. 2012;61:1766-9.

Normanno G, Firinu A, Virgilio S, Mulab G, Dambrosio A, Poggiu A, et al. Coagulase-positive Staphylococci and Staphylococcus aureus in food products marketed in Italy. Int J Food Microbiology. 2005;98:73-9.

Taylor TA, Unakal CG. Staphylococcus Aureus, In: Stat Pearls. Treasure Island (FL): Stat Pearls Publishing; 2018.

James M, Musser JM, Leoy DFR. Molecular Pathogenesis Lessons from the World of Infectious Diseases Research. Am J Pathology. 2015;185:6.

Clements A, Young JC, Constantinou N, Frankel G. Infection strategies of enteric pathogenic Escherichia coli. Gut Microbes. 2012;3:2:71-87.

Kielhofner M, Atmar RL, Hamill RJ, Mushe DM. Life-Threatening Pseudomonas aeruginosa Infections in Patients with Human Immunodeficiency Virus Infection. Clin Infectious Diseases. 1992;14:403-11.

Kucisec TN. Pseudomonas aeruginosa: a significant hospital pathogen and resistance to carbapenem. Acta Med Croatica. 2004;58(4):313-21.

Bodey GP, Bolivar R, Fainstein V, Jadeja L. Infections caused by Pseudomonas aeruginosa. Rev Infect Dis. 1983;5(2):279-313.

Allocati N, Masulli M, Alexeyev MF, Ili CD. Escherichia coli in Europe: An Overview. Int J Environ Res Public Health. 2013;10:6235-54.

Schmitz JE, Stratton CW. Neisseria meningitidis: Molecular Medical Microbiology (Second Edition); 2015.

Granoff DM, Lee H. Meningococcal vaccines; Harrison, in Vaccines (Sixth Edition); 2013.

Orr HJ, Gray SJ, Macdonald M, Stuart JM. Saliva and Meningococcal transmission. Emerg Infect Dis. 2003;9:1314-5.

Mahida N, Anthony L, Martin N, Gupta A, Andrewarth F. Human bite leading to fatal Neisseria meningitides septicaemia and pericarditis. JMM Case Reports; 2005.

Pridmore AC, Wyllie DH, Abdillahi F, Steeghs L, Ley PVD, Dower SK, et al. A Lipopolysaccharide-Deficient Mutant of Neisseria meningitidis Elicits Attenuated Cytokine Release by Human Macrophages and Signals via Toll-like Receptor (TLR) 2 but Not via TLR4/MD. J Infectious Diseases. 2001;183:89-9.

Hill DJ, Griffiths NJ, Borodina E, Mumtaz VIRJI. Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin Sci. 2010;118:547-64.

Sewell DL. Laboratory-Associated Infections and Biosafety. Clin Microbiology Reviews. 1995;8:389-405.

Sejvar JJ, Johnson D, Popovic T, Miller JM, Downes F, Somsel P, et al. Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol. 2005;43:4811-4.

US Labor Department’s OSHA concludes fatality investigation at San Francisco VA Medical Center research laboratory, issues violation notices. Available at https://www.osha.gov/news/news-releases/region9/02202013. Accessed 10 June 2020.

Miller G. Death of California researcher spurs investigation. Science. 2012;336:659.

Lamont JS, Blacksell SD. A Review of Laboratory-Acquired Infections in the Asia-Pacific: Understanding Risk and the Need for Improved Biosafety for Veterinary and Zoonotic Diseases. Trop Med Infect Dis. 2018;3(36):1-10.